Tag:
Actimis
Latest Headlines
Latest Headlines
Boehringer buys Actimis for $515
Boehringer Ingelheim is shelling out $515 million to acquire San Diego-based Actimis Pharmaceuticals, which is developing asthma and allergy drugs. Boehringer will acquire shares of Actimis as the
